Richard E. Doblin, Ph.D. - Publications

Affiliations: 
2001 Harvard University, Cambridge, MA, United States 
Area:
Public Administration, General, Clinical Psychology, Mental Health, United States History

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Jardim AV, Jardim DV, Chaves BR, Steglich M, Ot'alora G M, Mithoefer MC, da Silveira DX, Tófoli LF, Ribeiro S, Matthews R, Doblin R, Schenberg EE. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil. Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999). PMID 32638920 DOI: 10.1590/1516-4446-2020-0980  0.423
2020 Jerome L, Feduccia AA, Wang JB, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R. Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Psychopharmacology. PMID 32500209 DOI: 10.1007/S00213-020-05548-2  0.417
2019 Feduccia AA, Jerome L, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline. Frontiers in Psychiatry. 10: 650. PMID 31572236 DOI: 10.3389/Fpsyt.2019.00650  0.461
2019 Doblin RE, Christiansen M, Jerome L, Burge B. The Past and Future of Psychedelic Science: An Introduction to This Issue. Journal of Psychoactive Drugs. 51: 93-97. PMID 31132970 DOI: 10.1080/02791072.2019.1606472  0.325
2019 Mithoefer MC, Feduccia AA, Jerome L, Mithoefer A, Wagner M, Walsh Z, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R. MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. Psychopharmacology. PMID 31065731 DOI: 10.1007/S00213-019-05249-5  0.385
2018 Ot'alora G M, Grigsby J, Poulter B, Van Derveer JW, Giron SG, Jerome L, Feduccia AA, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer MC, Doblin R. 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology (Oxford, England). 269881118806297. PMID 30371148 DOI: 10.1177/0269881118806297  0.424
2018 Mithoefer MC, Mithoefer AT, Feduccia AA, Jerome L, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, Doblin R. 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: a randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet. Psychiatry. PMID 29728331 DOI: 10.1016/S2215-0366(18)30135-4  0.465
2017 Wagner MT, Mithoefer MC, Mithoefer AT, MacAulay RK, Jerome L, Yazar-Klosinski B, Doblin R. Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy. Journal of Psychopharmacology (Oxford, England). 269881117711712. PMID 28635375 DOI: 10.1177/0269881117711712  0.39
2014 Emerson A, Ponté L, Jerome L, Doblin R. History and Future of the Multidisciplinary Association for Psychedelic Studies (MAPS) Journal of Psychoactive Drugs. 46: 27-36. PMID 24830183 DOI: 10.1080/02791072.2014.877321  0.375
2014 Gasser P, Holstein DH, Michel Y, Doblin R, Yazar-Klosinski B, Passie T, Brenneisen RM. Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. Journal of Nervous and Mental Disease. 202: 513-520. PMID 24594678 DOI: 10.1097/Nmd.0000000000000113  0.372
2014 Doblin R, Greer G, Holland J, Jerome L, Mithoefer MC, Sessa B. A reconsideration and response to Parrott AC (2013) “Human psychobiology of MDMA or ‘Ecstasy’: an overview of 25 years of empirical research” Human Psychopharmacology-Clinical and Experimental. 29: 105-108. PMID 24590541 DOI: 10.1002/Hup.2389  0.343
2013 Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Martin SF, Yazar-Klosinski B, Michel Y, Brewerton TD, Doblin R. Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of Psychopharmacology (Oxford, England). 27: 28-39. PMID 23172889 DOI: 10.1177/0269881112456611  0.407
2011 Mithoefer MC, Wagner MT, Mithoefer AT, Jerome L, Doblin R. The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study Journal of Psychopharmacology. 25: 439-452. PMID 20643699 DOI: 10.1177/0269881110378371  0.425
2008 Bouso JC, Doblin R, Farré M, Alcázar MA, Gómez-Jarabo G. MDMA-assisted psychotherapy using low doses in a small sample of women with chronic posttraumatic stress disorder. Journal of Psychoactive Drugs. 40: 225-236. PMID 19004414 DOI: 10.1080/02791072.2008.10400637  0.352
2002 Doblin R. A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA. Journal of Psychoactive Drugs. 34: 185-194. PMID 12691208 DOI: 10.1080/02791072.2002.10399952  0.447
1998 Doblin R. Dr. Leary's Concord prison experiment : A 34-year follow-up study Journal of Psychoactive Drugs. 30: 419-426. PMID 9924845 DOI: 10.1080/02791072.1998.10399715  0.332
Show low-probability matches.